nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrofurantoin—ABCG2—lung cancer	0.379	1	CbGaD
Nitrofurantoin—POR—Doxorubicin—lung cancer	0.0943	0.197	CbGbCtD
Nitrofurantoin—ABCG2—Topotecan—lung cancer	0.0641	0.134	CbGbCtD
Nitrofurantoin—ABCG2—Gefitinib—lung cancer	0.0586	0.122	CbGbCtD
Nitrofurantoin—ABCG2—Teniposide—lung cancer	0.0569	0.119	CbGbCtD
Nitrofurantoin—ABCG2—Erlotinib—lung cancer	0.0347	0.0724	CbGbCtD
Nitrofurantoin—ABCG2—Paclitaxel—lung cancer	0.0317	0.0663	CbGbCtD
Nitrofurantoin—ABCG2—Irinotecan—lung cancer	0.0313	0.0654	CbGbCtD
Nitrofurantoin—ABCG2—Cisplatin—lung cancer	0.0255	0.0533	CbGbCtD
Nitrofurantoin—ABCG2—Etoposide—lung cancer	0.0251	0.0524	CbGbCtD
Nitrofurantoin—ABCG2—Docetaxel—lung cancer	0.0229	0.0479	CbGbCtD
Nitrofurantoin—ABCG2—Doxorubicin—lung cancer	0.0171	0.0357	CbGbCtD
Nitrofurantoin—ABCG2—Methotrexate—lung cancer	0.0166	0.0346	CbGbCtD
Nitrofurantoin—POR—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.0013	0.136	CbGpPWpGaD
Nitrofurantoin—POR—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000756	0.0789	CbGpPWpGaD
Nitrofurantoin—POR—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000643	0.0671	CbGpPWpGaD
Nitrofurantoin—ABCG2—Abacavir transmembrane transport—ABCB1—lung cancer	0.00063	0.0657	CbGpPWpGaD
Nitrofurantoin—ABCG2—Irinotecan Pathway—UGT1A1—lung cancer	0.000511	0.0533	CbGpPWpGaD
Nitrofurantoin—POR—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000462	0.0482	CbGpPWpGaD
Nitrofurantoin—ABCG2—Abacavir transport and metabolism—ABCB1—lung cancer	0.000362	0.0377	CbGpPWpGaD
Nitrofurantoin—ABCG2—Fluoropyrimidine Activity—RRM1—lung cancer	0.000322	0.0336	CbGpPWpGaD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—HMGB2—lung cancer	0.000309	0.0323	CbGpPWpGaD
Nitrofurantoin—ABCG2—Fluoropyrimidine Activity—ABCC3—lung cancer	0.000274	0.0285	CbGpPWpGaD
Nitrofurantoin—ABCG2—Fluoropyrimidine Activity—CYP2A6—lung cancer	0.00021	0.0219	CbGpPWpGaD
Nitrofurantoin—ABCG2—Irinotecan Pathway—APC—lung cancer	0.000199	0.0208	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—NDRG1—lung cancer	0.000185	0.0193	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—MCL1—lung cancer	0.000185	0.0193	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-2-alpha transcription factor network—FLT1—lung cancer	0.000184	0.0192	CbGpPWpGaD
Nitrofurantoin—POR—respiratory system—lung cancer	0.000179	0.184	CbGeAlD
Nitrofurantoin—ABCG2—Fluoropyrimidine Activity—SMUG1—lung cancer	0.000171	0.0178	CbGpPWpGaD
Nitrofurantoin—ABCG2—Iron uptake and transport—TF—lung cancer	0.000168	0.0175	CbGpPWpGaD
Nitrofurantoin—POR—bronchus—lung cancer	0.000147	0.152	CbGeAlD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—lung cancer	0.000138	0.0144	CbGpPWpGaD
Nitrofurantoin—ABCG2—Fluoropyrimidine Activity—TYMS—lung cancer	0.000137	0.0143	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—ALDOA—lung cancer	0.000136	0.0142	CbGpPWpGaD
Nitrofurantoin—POR—trachea—lung cancer	0.000132	0.136	CbGeAlD
Nitrofurantoin—ABCG2—Fluoropyrimidine Activity—ERCC2—lung cancer	0.000127	0.0133	CbGpPWpGaD
Nitrofurantoin—POR—cardiac atrium—lung cancer	0.000124	0.128	CbGeAlD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—TF—lung cancer	0.000119	0.0124	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—ENO1—lung cancer	0.000114	0.0119	CbGpPWpGaD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—lung cancer	0.000112	0.0117	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-2-alpha transcription factor network—KDR—lung cancer	0.000106	0.0111	CbGpPWpGaD
Nitrofurantoin—Renal impairment—Doxorubicin—lung cancer	0.000106	0.000809	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Docetaxel—lung cancer	0.000106	0.000807	CcSEcCtD
Nitrofurantoin—Malaise—Etoposide—lung cancer	0.000106	0.000807	CcSEcCtD
Nitrofurantoin—Vertigo—Etoposide—lung cancer	0.000106	0.000804	CcSEcCtD
Nitrofurantoin—Headache—Vinblastine—lung cancer	0.000105	0.000802	CcSEcCtD
Nitrofurantoin—Leukopenia—Etoposide—lung cancer	0.000105	0.000801	CcSEcCtD
Nitrofurantoin—POR—bone marrow—lung cancer	0.000105	0.108	CbGeAlD
Nitrofurantoin—Anaphylactic shock—Cisplatin—lung cancer	0.000105	0.000797	CcSEcCtD
Nitrofurantoin—Vomiting—Topotecan—lung cancer	0.000104	0.000791	CcSEcCtD
Nitrofurantoin—Malaise—Paclitaxel—lung cancer	0.000104	0.000791	CcSEcCtD
Nitrofurantoin—Paraesthesia—Irinotecan—lung cancer	0.000103	0.000788	CcSEcCtD
Nitrofurantoin—Vertigo—Paclitaxel—lung cancer	0.000103	0.000788	CcSEcCtD
Nitrofurantoin—Leukopenia—Paclitaxel—lung cancer	0.000103	0.000785	CcSEcCtD
Nitrofurantoin—Rash—Topotecan—lung cancer	0.000103	0.000784	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Vinorelbine—lung cancer	0.000103	0.000784	CcSEcCtD
Nitrofurantoin—Vomiting—Erlotinib—lung cancer	0.000103	0.000783	CcSEcCtD
Nitrofurantoin—Dyspnoea—Irinotecan—lung cancer	0.000103	0.000782	CcSEcCtD
Nitrofurantoin—Cough—Etoposide—lung cancer	0.000102	0.000781	CcSEcCtD
Nitrofurantoin—Somnolence—Irinotecan—lung cancer	0.000102	0.00078	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Cisplatin—lung cancer	0.000102	0.00078	CcSEcCtD
Nitrofurantoin—Headache—Topotecan—lung cancer	0.000102	0.000779	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000102	0.000779	CcSEcCtD
Nitrofurantoin—Rash—Erlotinib—lung cancer	0.000102	0.000776	CcSEcCtD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—lung cancer	0.000101	0.0106	CbGpPWpGaD
Nitrofurantoin—Dyspepsia—Irinotecan—lung cancer	0.000101	0.000773	CcSEcCtD
Nitrofurantoin—Headache—Erlotinib—lung cancer	0.000101	0.000771	CcSEcCtD
Nitrofurantoin—Asthma—Methotrexate—lung cancer	0.000101	0.000769	CcSEcCtD
Nitrofurantoin—Paraesthesia—Gemcitabine—lung cancer	0.000101	0.000768	CcSEcCtD
Nitrofurantoin—Chills—Docetaxel—lung cancer	0.000101	0.000766	CcSEcCtD
Nitrofurantoin—Cough—Paclitaxel—lung cancer	0.0001	0.000765	CcSEcCtD
Nitrofurantoin—Asthenia—Vinorelbine—lung cancer	0.0001	0.000764	CcSEcCtD
Nitrofurantoin—Decreased appetite—Irinotecan—lung cancer	0.0001	0.000763	CcSEcCtD
Nitrofurantoin—Dyspnoea—Gemcitabine—lung cancer	0.0001	0.000762	CcSEcCtD
Nitrofurantoin—Chest pain—Etoposide—lung cancer	0.0001	0.000762	CcSEcCtD
Nitrofurantoin—Eosinophilia—Methotrexate—lung cancer	9.99e-05	0.000761	CcSEcCtD
Nitrofurantoin—Nausea—Vinblastine—lung cancer	9.99e-05	0.000761	CcSEcCtD
Nitrofurantoin—Somnolence—Gemcitabine—lung cancer	9.98e-05	0.00076	CcSEcCtD
Nitrofurantoin—Anorexia—Cisplatin—lung cancer	9.97e-05	0.00076	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Irinotecan—lung cancer	9.95e-05	0.000758	CcSEcCtD
Nitrofurantoin—Alopecia—Docetaxel—lung cancer	9.91e-05	0.000755	CcSEcCtD
Nitrofurantoin—Discomfort—Etoposide—lung cancer	9.88e-05	0.000752	CcSEcCtD
Nitrofurantoin—Constipation—Irinotecan—lung cancer	9.85e-05	0.000751	CcSEcCtD
Nitrofurantoin—Myalgia—Paclitaxel—lung cancer	9.8e-05	0.000747	CcSEcCtD
Nitrofurantoin—Chest pain—Paclitaxel—lung cancer	9.8e-05	0.000747	CcSEcCtD
Nitrofurantoin—Decreased appetite—Gemcitabine—lung cancer	9.76e-05	0.000743	CcSEcCtD
Nitrofurantoin—Nausea—Topotecan—lung cancer	9.7e-05	0.000739	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Gemcitabine—lung cancer	9.69e-05	0.000738	CcSEcCtD
Nitrofurantoin—Discomfort—Paclitaxel—lung cancer	9.68e-05	0.000738	CcSEcCtD
Nitrofurantoin—Confusional state—Etoposide—lung cancer	9.66e-05	0.000736	CcSEcCtD
Nitrofurantoin—Constipation—Gemcitabine—lung cancer	9.6e-05	0.000731	CcSEcCtD
Nitrofurantoin—Nausea—Erlotinib—lung cancer	9.6e-05	0.000731	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Etoposide—lung cancer	9.58e-05	0.00073	CcSEcCtD
Nitrofurantoin—Diarrhoea—Vinorelbine—lung cancer	9.56e-05	0.000728	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Cisplatin—lung cancer	9.53e-05	0.000726	CcSEcCtD
Nitrofurantoin—POR—lung—lung cancer	9.5e-05	0.0979	CbGeAlD
Nitrofurantoin—Feeling abnormal—Irinotecan—lung cancer	9.49e-05	0.000723	CcSEcCtD
Nitrofurantoin—Confusional state—Paclitaxel—lung cancer	9.47e-05	0.000722	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Irinotecan—lung cancer	9.42e-05	0.000718	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Paclitaxel—lung cancer	9.4e-05	0.000716	CcSEcCtD
Nitrofurantoin—Paraesthesia—Cisplatin—lung cancer	9.39e-05	0.000716	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Etoposide—lung cancer	9.38e-05	0.000715	CcSEcCtD
Nitrofurantoin—Dyspnoea—Cisplatin—lung cancer	9.33e-05	0.00071	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Gemcitabine—lung cancer	9.25e-05	0.000704	CcSEcCtD
Nitrofurantoin—Dizziness—Vinorelbine—lung cancer	9.24e-05	0.000704	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Paclitaxel—lung cancer	9.2e-05	0.000701	CcSEcCtD
Nitrofurantoin—Anorexia—Etoposide—lung cancer	9.14e-05	0.000696	CcSEcCtD
Nitrofurantoin—Abdominal pain—Irinotecan—lung cancer	9.11e-05	0.000694	CcSEcCtD
Nitrofurantoin—Body temperature increased—Irinotecan—lung cancer	9.11e-05	0.000694	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Doxorubicin—lung cancer	9.11e-05	0.000694	CcSEcCtD
Nitrofurantoin—Decreased appetite—Cisplatin—lung cancer	9.09e-05	0.000693	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-2-alpha transcription factor network—CREBBP—lung cancer	9.08e-05	0.00948	CbGpPWpGaD
Nitrofurantoin—Gastrointestinal disorder—Cisplatin—lung cancer	9.03e-05	0.000688	CcSEcCtD
Nitrofurantoin—Anaemia—Docetaxel—lung cancer	9.02e-05	0.000687	CcSEcCtD
Nitrofurantoin—Drowsiness—Methotrexate—lung cancer	9e-05	0.000686	CcSEcCtD
Nitrofurantoin—Anorexia—Paclitaxel—lung cancer	8.96e-05	0.000682	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Methotrexate—lung cancer	8.92e-05	0.00068	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Doxorubicin—lung cancer	8.92e-05	0.000679	CcSEcCtD
Nitrofurantoin—Vomiting—Vinorelbine—lung cancer	8.88e-05	0.000677	CcSEcCtD
Nitrofurantoin—Body temperature increased—Gemcitabine—lung cancer	8.87e-05	0.000676	CcSEcCtD
Nitrofurantoin—Renal failure—Methotrexate—lung cancer	8.85e-05	0.000674	CcSEcCtD
Nitrofurantoin—Rash—Vinorelbine—lung cancer	8.81e-05	0.000671	CcSEcCtD
Nitrofurantoin—Headache—Vinorelbine—lung cancer	8.75e-05	0.000667	CcSEcCtD
Nitrofurantoin—Asthma—Doxorubicin—lung cancer	8.74e-05	0.000666	CcSEcCtD
Nitrofurantoin—Leukopenia—Docetaxel—lung cancer	8.74e-05	0.000665	CcSEcCtD
Nitrofurantoin—Eosinophilia—Doxorubicin—lung cancer	8.65e-05	0.000659	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Cisplatin—lung cancer	8.62e-05	0.000657	CcSEcCtD
Nitrofurantoin—Paraesthesia—Etoposide—lung cancer	8.61e-05	0.000656	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Paclitaxel—lung cancer	8.56e-05	0.000652	CcSEcCtD
Nitrofurantoin—Dyspnoea—Etoposide—lung cancer	8.54e-05	0.000651	CcSEcCtD
Nitrofurantoin—Somnolence—Etoposide—lung cancer	8.52e-05	0.000649	CcSEcCtD
Nitrofurantoin—Cough—Docetaxel—lung cancer	8.52e-05	0.000649	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Irinotecan—lung cancer	8.49e-05	0.000647	CcSEcCtD
Nitrofurantoin—Paraesthesia—Paclitaxel—lung cancer	8.44e-05	0.000643	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Methotrexate—lung cancer	8.4e-05	0.00064	CcSEcCtD
Nitrofurantoin—Dyspnoea—Paclitaxel—lung cancer	8.38e-05	0.000638	CcSEcCtD
Nitrofurantoin—Somnolence—Paclitaxel—lung cancer	8.35e-05	0.000636	CcSEcCtD
Nitrofurantoin—Decreased appetite—Etoposide—lung cancer	8.33e-05	0.000635	CcSEcCtD
Nitrofurantoin—Myalgia—Docetaxel—lung cancer	8.31e-05	0.000633	CcSEcCtD
Nitrofurantoin—Chest pain—Docetaxel—lung cancer	8.31e-05	0.000633	CcSEcCtD
Nitrofurantoin—Nausea—Vinorelbine—lung cancer	8.3e-05	0.000632	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Etoposide—lung cancer	8.27e-05	0.00063	CcSEcCtD
Nitrofurantoin—Dyspepsia—Paclitaxel—lung cancer	8.27e-05	0.00063	CcSEcCtD
Nitrofurantoin—Body temperature increased—Cisplatin—lung cancer	8.27e-05	0.00063	CcSEcCtD
Nitrofurantoin—Asthenia—Irinotecan—lung cancer	8.27e-05	0.00063	CcSEcCtD
Nitrofurantoin—Constipation—Etoposide—lung cancer	8.2e-05	0.000624	CcSEcCtD
Nitrofurantoin—Decreased appetite—Paclitaxel—lung cancer	8.17e-05	0.000622	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Paclitaxel—lung cancer	8.11e-05	0.000618	CcSEcCtD
Nitrofurantoin—Hepatitis—Methotrexate—lung cancer	8.08e-05	0.000615	CcSEcCtD
Nitrofurantoin—Asthenia—Gemcitabine—lung cancer	8.05e-05	0.000613	CcSEcCtD
Nitrofurantoin—Constipation—Paclitaxel—lung cancer	8.04e-05	0.000612	CcSEcCtD
Nitrofurantoin—Confusional state—Docetaxel—lung cancer	8.03e-05	0.000612	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—ABCB1—lung cancer	8e-05	0.00834	CbGpPWpGaD
Nitrofurantoin—Anaphylactic shock—Docetaxel—lung cancer	7.96e-05	0.000607	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Etoposide—lung cancer	7.9e-05	0.000602	CcSEcCtD
Nitrofurantoin—Diarrhoea—Irinotecan—lung cancer	7.88e-05	0.0006	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Etoposide—lung cancer	7.84e-05	0.000597	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Docetaxel—lung cancer	7.8e-05	0.000594	CcSEcCtD
Nitrofurantoin—Drowsiness—Doxorubicin—lung cancer	7.79e-05	0.000594	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Paclitaxel—lung cancer	7.74e-05	0.00059	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Doxorubicin—lung cancer	7.73e-05	0.000589	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Cisplatin—lung cancer	7.71e-05	0.000587	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Paclitaxel—lung cancer	7.68e-05	0.000585	CcSEcCtD
Nitrofurantoin—Diarrhoea—Gemcitabine—lung cancer	7.68e-05	0.000585	CcSEcCtD
Nitrofurantoin—Renal failure—Doxorubicin—lung cancer	7.66e-05	0.000584	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Methotrexate—lung cancer	7.64e-05	0.000582	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Doxorubicin—lung cancer	7.64e-05	0.000582	CcSEcCtD
Nitrofurantoin—Dizziness—Irinotecan—lung cancer	7.62e-05	0.00058	CcSEcCtD
Nitrofurantoin—Anorexia—Docetaxel—lung cancer	7.59e-05	0.000578	CcSEcCtD
Nitrofurantoin—Abdominal pain—Etoposide—lung cancer	7.58e-05	0.000577	CcSEcCtD
Nitrofurantoin—Body temperature increased—Etoposide—lung cancer	7.58e-05	0.000577	CcSEcCtD
Nitrofurantoin—Asthenia—Cisplatin—lung cancer	7.51e-05	0.000572	CcSEcCtD
Nitrofurantoin—Body temperature increased—Paclitaxel—lung cancer	7.43e-05	0.000566	CcSEcCtD
Nitrofurantoin—Abdominal pain—Paclitaxel—lung cancer	7.43e-05	0.000566	CcSEcCtD
Nitrofurantoin—Vomiting—Irinotecan—lung cancer	7.33e-05	0.000558	CcSEcCtD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—lung cancer	7.31e-05	0.00763	CbGpPWpGaD
Nitrofurantoin—Agranulocytosis—Doxorubicin—lung cancer	7.27e-05	0.000554	CcSEcCtD
Nitrofurantoin—Rash—Irinotecan—lung cancer	7.26e-05	0.000553	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Docetaxel—lung cancer	7.26e-05	0.000553	CcSEcCtD
Nitrofurantoin—Chills—Methotrexate—lung cancer	7.25e-05	0.000552	CcSEcCtD
Nitrofurantoin—Headache—Irinotecan—lung cancer	7.22e-05	0.00055	CcSEcCtD
Nitrofurantoin—Diarrhoea—Cisplatin—lung cancer	7.16e-05	0.000545	CcSEcCtD
Nitrofurantoin—Paraesthesia—Docetaxel—lung cancer	7.15e-05	0.000545	CcSEcCtD
Nitrofurantoin—Alopecia—Methotrexate—lung cancer	7.14e-05	0.000544	CcSEcCtD
Nitrofurantoin—Vomiting—Gemcitabine—lung cancer	7.14e-05	0.000544	CcSEcCtD
Nitrofurantoin—Dyspnoea—Docetaxel—lung cancer	7.1e-05	0.000541	CcSEcCtD
Nitrofurantoin—Somnolence—Docetaxel—lung cancer	7.08e-05	0.000539	CcSEcCtD
Nitrofurantoin—Rash—Gemcitabine—lung cancer	7.08e-05	0.000539	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Etoposide—lung cancer	7.06e-05	0.000538	CcSEcCtD
Nitrofurantoin—Headache—Gemcitabine—lung cancer	7.03e-05	0.000536	CcSEcCtD
Nitrofurantoin—Dyspepsia—Docetaxel—lung cancer	7.01e-05	0.000534	CcSEcCtD
Nitrofurantoin—Hepatitis—Doxorubicin—lung cancer	7e-05	0.000533	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Doxorubicin—lung cancer	6.96e-05	0.00053	CcSEcCtD
Nitrofurantoin—Decreased appetite—Docetaxel—lung cancer	6.92e-05	0.000527	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Paclitaxel—lung cancer	6.92e-05	0.000527	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Docetaxel—lung cancer	6.88e-05	0.000524	CcSEcCtD
Nitrofurantoin—Asthenia—Etoposide—lung cancer	6.88e-05	0.000524	CcSEcCtD
Nitrofurantoin—Nausea—Irinotecan—lung cancer	6.84e-05	0.000521	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—TERT—lung cancer	6.84e-05	0.00714	CbGpPWpGaD
Nitrofurantoin—Constipation—Docetaxel—lung cancer	6.81e-05	0.000519	CcSEcCtD
Nitrofurantoin—Asthenia—Paclitaxel—lung cancer	6.74e-05	0.000514	CcSEcCtD
Nitrofurantoin—Nausea—Gemcitabine—lung cancer	6.67e-05	0.000508	CcSEcCtD
Nitrofurantoin—Vomiting—Cisplatin—lung cancer	6.65e-05	0.000507	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Doxorubicin—lung cancer	6.62e-05	0.000504	CcSEcCtD
Nitrofurantoin—Rash—Cisplatin—lung cancer	6.6e-05	0.000502	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Docetaxel—lung cancer	6.56e-05	0.0005	CcSEcCtD
Nitrofurantoin—Diarrhoea—Etoposide—lung cancer	6.56e-05	0.000499	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—HIF1A—lung cancer	6.54e-05	0.00683	CbGpPWpGaD
Nitrofurantoin—Ill-defined disorder—Methotrexate—lung cancer	6.53e-05	0.000497	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Docetaxel—lung cancer	6.51e-05	0.000496	CcSEcCtD
Nitrofurantoin—Anaemia—Methotrexate—lung cancer	6.5e-05	0.000495	CcSEcCtD
Nitrofurantoin—POR—lymph node—lung cancer	6.5e-05	0.0669	CbGeAlD
Nitrofurantoin—Diarrhoea—Paclitaxel—lung cancer	6.43e-05	0.00049	CcSEcCtD
Nitrofurantoin—Malaise—Methotrexate—lung cancer	6.34e-05	0.000483	CcSEcCtD
Nitrofurantoin—Dizziness—Etoposide—lung cancer	6.34e-05	0.000483	CcSEcCtD
Nitrofurantoin—Vertigo—Methotrexate—lung cancer	6.32e-05	0.000481	CcSEcCtD
Nitrofurantoin—Abdominal pain—Docetaxel—lung cancer	6.3e-05	0.00048	CcSEcCtD
Nitrofurantoin—Body temperature increased—Docetaxel—lung cancer	6.3e-05	0.00048	CcSEcCtD
Nitrofurantoin—Leukopenia—Methotrexate—lung cancer	6.3e-05	0.00048	CcSEcCtD
Nitrofurantoin—Chills—Doxorubicin—lung cancer	6.28e-05	0.000478	CcSEcCtD
Nitrofurantoin—Dizziness—Paclitaxel—lung cancer	6.21e-05	0.000473	CcSEcCtD
Nitrofurantoin—Nausea—Cisplatin—lung cancer	6.21e-05	0.000473	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-2-alpha transcription factor network—EP300—lung cancer	6.19e-05	0.00646	CbGpPWpGaD
Nitrofurantoin—Alopecia—Doxorubicin—lung cancer	6.18e-05	0.000471	CcSEcCtD
Nitrofurantoin—Cough—Methotrexate—lung cancer	6.14e-05	0.000468	CcSEcCtD
Nitrofurantoin—Vomiting—Etoposide—lung cancer	6.09e-05	0.000464	CcSEcCtD
Nitrofurantoin—Rash—Etoposide—lung cancer	6.04e-05	0.00046	CcSEcCtD
Nitrofurantoin—Headache—Etoposide—lung cancer	6e-05	0.000457	CcSEcCtD
Nitrofurantoin—Flatulence—Doxorubicin—lung cancer	6e-05	0.000457	CcSEcCtD
Nitrofurantoin—Chest pain—Methotrexate—lung cancer	5.99e-05	0.000456	CcSEcCtD
Nitrofurantoin—Myalgia—Methotrexate—lung cancer	5.99e-05	0.000456	CcSEcCtD
Nitrofurantoin—Vomiting—Paclitaxel—lung cancer	5.97e-05	0.000455	CcSEcCtD
Nitrofurantoin—Rash—Paclitaxel—lung cancer	5.92e-05	0.000451	CcSEcCtD
Nitrofurantoin—Discomfort—Methotrexate—lung cancer	5.92e-05	0.000451	CcSEcCtD
Nitrofurantoin—Headache—Paclitaxel—lung cancer	5.89e-05	0.000448	CcSEcCtD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—SLC34A2—lung cancer	5.87e-05	0.00613	CbGpPWpGaD
Nitrofurantoin—Hypersensitivity—Docetaxel—lung cancer	5.87e-05	0.000447	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-2-alpha transcription factor network—VEGFA—lung cancer	5.86e-05	0.00611	CbGpPWpGaD
Nitrofurantoin—Confusional state—Methotrexate—lung cancer	5.79e-05	0.000441	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Methotrexate—lung cancer	5.74e-05	0.000437	CcSEcCtD
Nitrofurantoin—Asthenia—Docetaxel—lung cancer	5.71e-05	0.000435	CcSEcCtD
Nitrofurantoin—Nausea—Etoposide—lung cancer	5.69e-05	0.000434	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Doxorubicin—lung cancer	5.65e-05	0.00043	CcSEcCtD
Nitrofurantoin—Anaemia—Doxorubicin—lung cancer	5.63e-05	0.000429	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Methotrexate—lung cancer	5.62e-05	0.000428	CcSEcCtD
Nitrofurantoin—Nausea—Paclitaxel—lung cancer	5.58e-05	0.000425	CcSEcCtD
Nitrofurantoin—Malaise—Doxorubicin—lung cancer	5.49e-05	0.000418	CcSEcCtD
Nitrofurantoin—Vertigo—Doxorubicin—lung cancer	5.47e-05	0.000417	CcSEcCtD
Nitrofurantoin—Anorexia—Methotrexate—lung cancer	5.47e-05	0.000417	CcSEcCtD
Nitrofurantoin—Leukopenia—Doxorubicin—lung cancer	5.45e-05	0.000415	CcSEcCtD
Nitrofurantoin—Diarrhoea—Docetaxel—lung cancer	5.45e-05	0.000415	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—CREBBP—lung cancer	5.34e-05	0.00558	CbGpPWpGaD
Nitrofurantoin—Cough—Doxorubicin—lung cancer	5.31e-05	0.000405	CcSEcCtD
Nitrofurantoin—Dizziness—Docetaxel—lung cancer	5.27e-05	0.000401	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Methotrexate—lung cancer	5.23e-05	0.000398	CcSEcCtD
Nitrofurantoin—Chest pain—Doxorubicin—lung cancer	5.19e-05	0.000395	CcSEcCtD
Nitrofurantoin—Myalgia—Doxorubicin—lung cancer	5.19e-05	0.000395	CcSEcCtD
Nitrofurantoin—Paraesthesia—Methotrexate—lung cancer	5.15e-05	0.000393	CcSEcCtD
Nitrofurantoin—Discomfort—Doxorubicin—lung cancer	5.12e-05	0.00039	CcSEcCtD
Nitrofurantoin—Dyspnoea—Methotrexate—lung cancer	5.12e-05	0.00039	CcSEcCtD
Nitrofurantoin—Somnolence—Methotrexate—lung cancer	5.1e-05	0.000389	CcSEcCtD
Nitrofurantoin—Vomiting—Docetaxel—lung cancer	5.06e-05	0.000386	CcSEcCtD
Nitrofurantoin—Dyspepsia—Methotrexate—lung cancer	5.05e-05	0.000385	CcSEcCtD
Nitrofurantoin—Rash—Docetaxel—lung cancer	5.02e-05	0.000383	CcSEcCtD
Nitrofurantoin—Confusional state—Doxorubicin—lung cancer	5.01e-05	0.000382	CcSEcCtD
Nitrofurantoin—Decreased appetite—Methotrexate—lung cancer	4.99e-05	0.00038	CcSEcCtD
Nitrofurantoin—Headache—Docetaxel—lung cancer	4.99e-05	0.00038	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Doxorubicin—lung cancer	4.97e-05	0.000379	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Methotrexate—lung cancer	4.96e-05	0.000378	CcSEcCtD
Nitrofurantoin—ABCG2—bone marrow—lung cancer	4.87e-05	0.0502	CbGeAlD
Nitrofurantoin—Thrombocytopenia—Doxorubicin—lung cancer	4.87e-05	0.000371	CcSEcCtD
Nitrofurantoin—Anorexia—Doxorubicin—lung cancer	4.74e-05	0.000361	CcSEcCtD
Nitrofurantoin—Nausea—Docetaxel—lung cancer	4.73e-05	0.00036	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Methotrexate—lung cancer	4.73e-05	0.00036	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Methotrexate—lung cancer	4.69e-05	0.000358	CcSEcCtD
Nitrofurantoin—Body temperature increased—Methotrexate—lung cancer	4.54e-05	0.000346	CcSEcCtD
Nitrofurantoin—Abdominal pain—Methotrexate—lung cancer	4.54e-05	0.000346	CcSEcCtD
Nitrofurantoin—ABCG2—Fluoropyrimidine Activity—TP53—lung cancer	4.53e-05	0.00473	CbGpPWpGaD
Nitrofurantoin—Musculoskeletal discomfort—Doxorubicin—lung cancer	4.53e-05	0.000345	CcSEcCtD
Nitrofurantoin—Paraesthesia—Doxorubicin—lung cancer	4.46e-05	0.00034	CcSEcCtD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—SLC22A18—lung cancer	4.45e-05	0.00464	CbGpPWpGaD
Nitrofurantoin—Dyspnoea—Doxorubicin—lung cancer	4.43e-05	0.000338	CcSEcCtD
Nitrofurantoin—Somnolence—Doxorubicin—lung cancer	4.42e-05	0.000337	CcSEcCtD
Nitrofurantoin—ABCG2—lung—lung cancer	4.41e-05	0.0455	CbGeAlD
Nitrofurantoin—Dyspepsia—Doxorubicin—lung cancer	4.38e-05	0.000333	CcSEcCtD
Nitrofurantoin—Decreased appetite—Doxorubicin—lung cancer	4.32e-05	0.000329	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Doxorubicin—lung cancer	4.29e-05	0.000327	CcSEcCtD
Nitrofurantoin—Constipation—Doxorubicin—lung cancer	4.25e-05	0.000324	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Methotrexate—lung cancer	4.23e-05	0.000322	CcSEcCtD
Nitrofurantoin—Asthenia—Methotrexate—lung cancer	4.12e-05	0.000314	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Doxorubicin—lung cancer	4.1e-05	0.000312	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Doxorubicin—lung cancer	4.06e-05	0.00031	CcSEcCtD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—lung cancer	4.02e-05	0.0042	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—JUN—lung cancer	3.95e-05	0.00412	CbGpPWpGaD
Nitrofurantoin—Body temperature increased—Doxorubicin—lung cancer	3.93e-05	0.000299	CcSEcCtD
Nitrofurantoin—Abdominal pain—Doxorubicin—lung cancer	3.93e-05	0.000299	CcSEcCtD
Nitrofurantoin—Diarrhoea—Methotrexate—lung cancer	3.93e-05	0.000299	CcSEcCtD
Nitrofurantoin—Dizziness—Methotrexate—lung cancer	3.8e-05	0.000289	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Doxorubicin—lung cancer	3.66e-05	0.000279	CcSEcCtD
Nitrofurantoin—Vomiting—Methotrexate—lung cancer	3.65e-05	0.000278	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—EP300—lung cancer	3.64e-05	0.0038	CbGpPWpGaD
Nitrofurantoin—Rash—Methotrexate—lung cancer	3.62e-05	0.000276	CcSEcCtD
Nitrofurantoin—Headache—Methotrexate—lung cancer	3.6e-05	0.000274	CcSEcCtD
Nitrofurantoin—Asthenia—Doxorubicin—lung cancer	3.57e-05	0.000272	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—lung cancer	3.45e-05	0.0036	CbGpPWpGaD
Nitrofurantoin—Nausea—Methotrexate—lung cancer	3.41e-05	0.00026	CcSEcCtD
Nitrofurantoin—Diarrhoea—Doxorubicin—lung cancer	3.4e-05	0.000259	CcSEcCtD
Nitrofurantoin—Dizziness—Doxorubicin—lung cancer	3.29e-05	0.00025	CcSEcCtD
Nitrofurantoin—Vomiting—Doxorubicin—lung cancer	3.16e-05	0.000241	CcSEcCtD
Nitrofurantoin—Rash—Doxorubicin—lung cancer	3.13e-05	0.000239	CcSEcCtD
Nitrofurantoin—Headache—Doxorubicin—lung cancer	3.11e-05	0.000237	CcSEcCtD
Nitrofurantoin—ABCG2—lymph node—lung cancer	3.02e-05	0.0311	CbGeAlD
Nitrofurantoin—ABCG2—Metabolism—AZIN2—lung cancer	3.01e-05	0.00314	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—COL4A3BP—lung cancer	3.01e-05	0.00314	CbGpPWpGaD
Nitrofurantoin—Nausea—Doxorubicin—lung cancer	2.95e-05	0.000225	CcSEcCtD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—ABCC3—lung cancer	2.67e-05	0.00278	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ATP5H—lung cancer	2.56e-05	0.00267	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—GNG11—lung cancer	2.42e-05	0.00252	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PLBD1—lung cancer	2.28e-05	0.00238	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—AKT1—lung cancer	2.2e-05	0.00229	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—ADCY1—lung cancer	2.17e-05	0.00227	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—HSD17B10—lung cancer	2.08e-05	0.00218	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—TF—lung cancer	2.02e-05	0.00211	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CKB—lung cancer	1.94e-05	0.00202	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GSTM2—lung cancer	1.82e-05	0.0019	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CNDP2—lung cancer	1.82e-05	0.0019	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—MTMR3—lung cancer	1.77e-05	0.00185	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PGAM1—lung cancer	1.73e-05	0.0018	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CYP2A7—lung cancer	1.65e-05	0.00172	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—SDC4—lung cancer	1.61e-05	0.00168	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—RRM1—lung cancer	1.47e-05	0.00153	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GSTA3—lung cancer	1.47e-05	0.00153	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—AVP—lung cancer	1.4e-05	0.00146	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—B4GALT5—lung cancer	1.38e-05	0.00144	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—ABCB1—lung cancer	1.36e-05	0.00142	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GSTA4—lung cancer	1.34e-05	0.0014	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GSTA2—lung cancer	1.31e-05	0.00137	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GSTA1—lung cancer	1.26e-05	0.00132	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ABCC3—lung cancer	1.25e-05	0.0013	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—AKR1C1—lung cancer	1.21e-05	0.00126	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—UGT1A1—lung cancer	1.17e-05	0.00123	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GNG11—lung cancer	1.13e-05	0.00118	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ALDOA—lung cancer	1.08e-05	0.00112	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—APOA1—lung cancer	1.07e-05	0.00112	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—NCOA3—lung cancer	1.05e-05	0.00109	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ADCY1—lung cancer	1.02e-05	0.00106	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ENO2—lung cancer	9.99e-06	0.00104	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—HPGDS—lung cancer	9.99e-06	0.00104	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PPP2R1B—lung cancer	9.92e-06	0.00104	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GSTT1—lung cancer	9.68e-06	0.00101	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GCLC—lung cancer	9.57e-06	0.000999	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CYP2A6—lung cancer	9.57e-06	0.000999	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ENO1—lung cancer	9.08e-06	0.000947	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—CREBBP—lung cancer	9.07e-06	0.000946	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—ALB—lung cancer	8.49e-06	0.000886	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CYP2E1—lung cancer	8.14e-06	0.000849	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—NQO1—lung cancer	8.05e-06	0.00084	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—RAF1—lung cancer	7.68e-06	0.000801	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—STK11—lung cancer	7.26e-06	0.000757	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GSTP1—lung cancer	6.71e-06	0.0007	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CAT—lung cancer	6.53e-06	0.000682	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ABCB1—lung cancer	6.35e-06	0.000663	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—TYMS—lung cancer	6.24e-06	0.000651	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GSTM1—lung cancer	6.17e-06	0.000644	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CYP1A1—lung cancer	5.85e-06	0.00061	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ERCC2—lung cancer	5.8e-06	0.000605	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—APOA1—lung cancer	5.02e-06	0.000524	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PIK3CG—lung cancer	4.58e-06	0.000478	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—POMC—lung cancer	4.36e-06	0.000455	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CREBBP—lung cancer	4.25e-06	0.000443	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PIK3CD—lung cancer	4.03e-06	0.00042	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ALB—lung cancer	3.98e-06	0.000415	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PIK3CB—lung cancer	3.51e-06	0.000366	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PTGS2—lung cancer	3.48e-06	0.000363	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PTEN—lung cancer	3.03e-06	0.000316	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—EP300—lung cancer	2.89e-06	0.000302	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PIK3CA—lung cancer	2.14e-06	0.000223	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—AKT1—lung cancer	1.75e-06	0.000182	CbGpPWpGaD
